JP2004507501A5 - - Google Patents

Download PDF

Info

Publication number
JP2004507501A5
JP2004507501A5 JP2002522888A JP2002522888A JP2004507501A5 JP 2004507501 A5 JP2004507501 A5 JP 2004507501A5 JP 2002522888 A JP2002522888 A JP 2002522888A JP 2002522888 A JP2002522888 A JP 2002522888A JP 2004507501 A5 JP2004507501 A5 JP 2004507501A5
Authority
JP
Japan
Prior art keywords
phenyl
branched
methylene
phenylmethoxy
thioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002522888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004507501A (ja
Filing date
Publication date
Priority claimed from GBGB0021421.3A external-priority patent/GB0021421D0/en
Application filed filed Critical
Publication of JP2004507501A publication Critical patent/JP2004507501A/ja
Publication of JP2004507501A5 publication Critical patent/JP2004507501A5/ja
Pending legal-status Critical Current

Links

JP2002522888A 2000-08-31 2001-08-30 ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用 Pending JP2004507501A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021421.3A GB0021421D0 (en) 2000-08-31 2000-08-31 Compounds
PCT/GB2001/003862 WO2002017915A1 (en) 2000-08-31 2001-08-30 Benzylidene thiazolidinediones and their use as antimycotic agents

Publications (2)

Publication Number Publication Date
JP2004507501A JP2004507501A (ja) 2004-03-11
JP2004507501A5 true JP2004507501A5 (enExample) 2005-04-14

Family

ID=9898616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002522888A Pending JP2004507501A (ja) 2000-08-31 2001-08-30 ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用

Country Status (9)

Country Link
US (1) US7105554B2 (enExample)
EP (1) EP1313471B1 (enExample)
JP (1) JP2004507501A (enExample)
AT (1) ATE359073T1 (enExample)
AU (1) AU2001284190A1 (enExample)
DE (1) DE60127845T2 (enExample)
ES (1) ES2282283T3 (enExample)
GB (1) GB0021421D0 (enExample)
WO (1) WO2002017915A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070238A1 (en) * 2002-02-23 2003-08-28 Oxford Glycosciences (Uk) Ltd Thiazolidine antifungal agents
GB0204252D0 (en) * 2002-02-23 2002-04-10 Oxford Glycosciences Uk Ltd Novel compounds
PL1730103T3 (pl) 2004-03-23 2010-10-29 Pfizer Pochodne formamidu użyteczne jako adrenoreceptor
EP1954815B1 (en) * 2005-11-15 2015-02-25 GlycoFi, Inc. Production of glycoproteins with reduced o-glycosylation
US7731106B2 (en) * 2006-01-04 2010-06-08 Nano Mist International, Llc Air driven delivery system for sprayable media
US8637435B2 (en) * 2007-11-16 2014-01-28 Merck Sharp & Dohme Corp. Eukaryotic cell display systems
CA2715212A1 (en) 2008-03-03 2009-09-11 Glycofi, Inc. Surface display of recombinant proteins in lower eukaryotes
ATE536347T1 (de) 2008-05-20 2011-12-15 Merck Sharp & Dohme Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
US8067339B2 (en) * 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
WO2010019487A1 (en) 2008-08-12 2010-02-18 Glycofi, Inc. Improved vectors and yeast strains for protein production: ca2+ atpase overexpression
WO2012115903A2 (en) 2011-02-25 2012-08-30 Merck Sharp & Dohme Corp. Yeast strain for the production of proteins with modified o-glycosylation
BR112014001265A2 (pt) * 2011-07-29 2017-02-21 Taisho Pharmaceutical Co Ltd composto de amidina ou seu sal
WO2014024897A1 (ja) * 2012-08-06 2014-02-13 Meiji Seikaファルマ株式会社 チアゾリジンジオンおよびピロリジンジオン誘導体、並びにそれらを有効成分としてなる殺菌剤
WO2014062811A2 (en) * 2012-10-16 2014-04-24 New York University METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2
RU2016103373A (ru) 2013-07-04 2017-08-10 Новартис Аг Клетки нитчатых грибов с дефицитом о-маннозилтрансферазы и способы их применения
AU2015293949B2 (en) 2014-07-21 2019-07-25 Teknologian Tutkimuskeskus Vtt Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
US20190307729A1 (en) 2016-06-14 2019-10-10 Versitech Limited Antimicrobial compounds and methods for use thereof
US10647654B2 (en) 2016-06-24 2020-05-12 Ohio University Glucose transport inhibitors and methods of using same
RU2662153C1 (ru) * 2017-04-20 2018-07-24 Общество С Ограниченной Ответственностью "Дермавитал Групп" Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение
RU2690161C1 (ru) * 2018-06-28 2019-05-31 Общество С Ограниченной Ответственностью "Дермавитал Групп" 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью
RU2703997C1 (ru) * 2018-12-13 2019-10-23 Общество с ограниченной ответственностью "Л-Био" Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью
CN112521382A (zh) * 2020-12-14 2021-03-19 西南大学 芦荟大黄素噻唑烷二酮类化合物及其制备方法和应用
WO2024258316A1 (ru) * 2023-06-16 2024-12-19 Общество с ограниченной ответственностью "Л-Био" Новые потенциальные противогрибковые средства на основе тиазолидин-2,4-диона и триазола

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6156175A (ja) * 1984-08-24 1986-03-20 Yamanouchi Pharmaceut Co Ltd ロダニン誘導体およびその製造法
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JPH08109175A (ja) * 1994-10-07 1996-04-30 Torii Yakuhin Kk チアゾリジン−2−オンエステル誘導体
JPH08109174A (ja) * 1994-10-07 1996-04-30 Torii Yakuhin Kk チアゾリジン−2−オン誘導体
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU6330799A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
US6506755B2 (en) * 2000-02-03 2003-01-14 Hoffmann-La Roche Inc. Thiazolidinecarboxyl acids

Similar Documents

Publication Publication Date Title
JP2003520235A5 (enExample)
JP2004534035A5 (enExample)
JP2005539088A5 (enExample)
JP2006517572A5 (enExample)
JP2004509121A5 (enExample)
JP2004520292A5 (enExample)
JP2007519695A5 (enExample)
JP2004532229A5 (enExample)
JP2006510627A5 (enExample)
JP2007511485A5 (enExample)
JP2004518725A5 (enExample)
JP2006509749A5 (enExample)
JP2007523181A5 (enExample)
JP2010521471A5 (enExample)
JP2002513793A5 (enExample)
JP2009520769A5 (enExample)
CA2294809A1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
JP2014523400A5 (enExample)
JP2007502265A5 (enExample)
RU2383542C2 (ru) Замещенные гидантоины
JP2006506340A5 (enExample)
JP2004517100A5 (enExample)
JP2007515467A5 (enExample)
JP2004517151A5 (enExample)
JPH10130212A5 (enExample)